InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Komjathy Andrew, Directeur Commercial. Director active across 1 companies, notably Astria Therapeutics, Inc.. Aggregated, 2 reports have been published. Total volume traded: €1k. The latest transaction was filed on 19 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€589100 shares@ €5.8891100.0% of flow
Common Stock
SEC:0001104659-21-143035·
Ideal exit: 16 Aug 2022 (T+270)
€589100 shares@ €5.889150.0% of flow
Common Stock
SEC:0001104659-21-143035:0·
Ideal exit: 16 Aug 2022 (T+270)
2 of 2 declarations
About Komjathy Andrew
Komjathy Andrew is the Chief Commercial Officer at Astria Therapeutics, Inc. He oversees commercial operations and contributes to the company's growth strategy.
